Skip to content

Efficacy transdiagnostic therapy in the treatment of generalized anxiety disorder

Efficacy effect of integrated transdiagnostic treatment on reducing the symptoms in individuals with general anxiety disorder and its co-morbidity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120619010063N7
Enrollment
24
Registered
2018-05-11
Start date
2018-04-04
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

generalized anxiety disorder. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: 12 sessions of integrated transdiagnostic treatment of Barlow and colleagues-It has 5 main sections(Teaching awareness of emotions, cognitive flexibility, emotiona

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having at least 18 years of age Have at least 3rd grade education A person experiences generalized anxiety disorder as the primary diagnosis based on a psychiatrist's diagnosis and a diagnostic interview by a psychologist Motivation and satisfaction for participation during treatment and research implementation

Exclusion criteria

Exclusion criteria: The current diagnosis of any mental disorder is consistent in Diagrams 1 and 2 based on a psychologist's diagnostic interview, with the exception of emotional disturbances The current risk of suicide Not receiving psychological treatment in the past year Abuse history or substance dependence currently and over a year before the start of treatment Unwillingness to attend research meetings

Design outcomes

Primary

MeasureTime frame
Genralized anxiety. Timepoint: pre-test, post-test, two months follow up. Method of measurement: Penn State Worry Questionnaire.

Secondary

MeasureTime frame
Depression. Timepoint: pre-test, post-test, two months follow up. Method of measurement: Beck Depression Inventory - Second Edition.;Social anxiety. Timepoint: pre-test, post-test, two months follow up. Method of measurement: Social Interaction Anxiety Scale.;Health Anxiety. Timepoint: pre-test, post-test, two months follow up. Method of measurement: Short Form-Health Anxiety Inventory.;Sleep quality. Timepoint: pre-test, post-test, two months follow up. Method of measurement: Pittsburgh Sleep Quality Index.;Work and Social Adjustment. Timepoint: pre-test, post-test, two months follow up. Method of measurement: work and Social Adjustment Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Mohammadpour

Kermanshah University of Medical Sciences

mohammdpour5711@gmail.com+98 83 3835 5925

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026